MELISSA ANDRUS: Open Payments
NPI 1023526696 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 29 payments from 6 companies in 2025. Trend: 2023 $1,062 · 2024 $317 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $268 |
| E.R. Squibb & Sons, L.L.C. | 2 | $218 |
| Axsome Therapeutics, Inc. | 4 | $140 |
| Otsuka America Pharmaceutical, Inc. | 5 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
Products named: VRAYLAR, COBENFY, Auvelity, REXULTI, CAPLYTA, Jornay PM.
Industry payments across PA — which companies pay providers there.
